Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Jørgensen, H. A.
and
Cappelen, C.
1982.
Naloxone‐induced reduction of schizophrenic symptoms A CASE REPORT.
Acta Psychiatrica Scandinavica,
Vol. 65,
Issue. 5,
p.
370.
Naber, D.
Münch, U.
Wissmann, J.
Grosse, R.
Ritt, R.
and
Welter, D.
1983.
Naloxone treatment for five days ineffective in schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 67,
Issue. 4,
p.
265.
Janowsky, David S.
Judd, Lewis L.
Huey, Leighton Y.
Risch, Samuel Craig
and
Segal, David S.
1983.
Behavioral Effects of Opioid Receptor Antagonists in Psychopathologic States.
Psychiatric Clinics of North America,
Vol. 6,
Issue. 3,
p.
403.
Tariot, Pierre N.
Sunderland, Trey
Murphy, Dennis L.
Cohen, Martin R.
Welkowitz, Julie A.
Weingartner, Herbert
Newhouse, Paul A.
and
Cohen, Robert M.
1986.
Design and interpretation of opiate antagonist trials in dementia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 10,
Issue. 3-5,
p.
611.
Naber, Dieter
1988.
Clinical relevance of endorphins in psychiatry.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 12,
Issue. ,
p.
S119.
Naber, D.
1993.
Opioids II.
Vol. 104 / 2,
Issue. ,
p.
781.
Hoff, Paul
1994.
Emil Kraepelin und die Psychiatrie als klinische Wissenschaft.
Vol. 73,
Issue. ,
p.
215.
Welch, E. B.
and
Thompson, D. F.
1994.
Opiate antagonists for the treatment of schizophrenia.
Journal of Clinical Pharmacy and Therapeutics,
Vol. 19,
Issue. 5,
p.
279.
Cáceda, Ricardo
Kinkead, Becky
and
Nemeroff, Charles B.
2007.
Integrating the Neurobiology of Schizophrenia.
Vol. 78,
Issue. ,
p.
327.
Clark, Samuel David
and
Abi-Dargham, Anissa
2019.
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.
Biological Psychiatry,
Vol. 86,
Issue. 7,
p.
502.
Clark, Samuel D.
Van Snellenberg, Jared X.
Lawson, Jacqueline M.
and
Abi-Dargham, Anissa
2020.
Opioid antagonists are associated with a reduction in the symptoms of schizophrenia: a meta-analysis of controlled trials.
Neuropsychopharmacology,
Vol. 45,
Issue. 11,
p.
1860.
eLetters
No eLetters have been published for this article.